Edition:
United States

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

23.35CNY
2:59am EDT
Change (% chg)

¥-0.17 (-0.72%)
Prev Close
¥23.52
Open
¥23.50
Day's High
¥23.59
Day's Low
¥23.10
Volume
3,954,443
Avg. Vol
3,672,801
52-wk High
¥24.66
52-wk Low
¥16.60

Latest Key Developments (Source: Significant Developments)

China Resources Double-Crane Pharma to pay annual dividend for FY 2016
Tuesday, 14 Mar 2017 04:37am EDT 

China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS> : Says it will use undistributed profits to pay a cash of 0.99 yuan(pre-tax)/10 shares to shareholders for FY 2016 .Says it will distribute 2 shares/10 shares as stock dividends.  Full Article

China Resources Double-Crane Pharma's 2016 net profit up 8 pct y/y
Thursday, 9 Mar 2017 02:25am EST 

China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS> :Says 2016 net profit up 8.0 percent y/y at 714.2 million yuan ($103.38 million).  Full Article

China Resources Double-crane Pharma's unit to buy pharma firm for 850 mln yuan
Tuesday, 20 Dec 2016 07:00am EST 

China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> :Says its unit plans to buy a pharma firm for 850 million yuan ($122.33 million).  Full Article

China Resources Double-Crane Pharma's H1 net profit up 5.6 pct
Sunday, 14 Aug 2016 11:45pm EDT 

China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS> :Says its H1 net profit up 5.6 pct y/y at 433.5 million yuan ($65.22 million).  Full Article

China Resources Double-Crane Pharmaceutical to pay 2015 div on July 20
Wednesday, 13 Jul 2016 02:06am EDT 

China Resources Double-Crane Pharmaceutical <600062.SS> Co., Ltd.: Says it will pay cash dividend of 1.85 yuan per 10 shares (before tax) to shareholders for 2015 as a record of July 19 .Says the company's shares will be traded ex-right and ex-dividend on July 20 and the dividend will be paid on July 20.  Full Article

China Resources Double-Crane Pharmaceutical passes CEP approval
Tuesday, 22 Mar 2016 08:00pm EDT 

China Resources Double-Crane Pharmaceutical Co Ltd:Receives approval for its olmesartan medoxomil from European Directorate for Quality of Medicines & HealthCare.Company will be able to sell its olmesartan medoxomil in Europe after receiving the CEP approval.  Full Article

China Resources Double-Crane Pharmaceutical says 2015 dividend payment as 0.185 yuan per share
Thursday, 10 Mar 2016 07:00pm EST 

China Resources Double-Crane Pharmaceutical Co Ltd:To pay cash dividend of 1.85 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

China Resources Double-Crane Pharmaceutical subsidiary drug clinical trials approval document
Tuesday, 1 Mar 2016 07:00pm EST 

China Resources Double-Crane Pharmaceutical Co Ltd:Wholly owned subsidiary drug clinical trials approval document, for ezetimibe tablets (10mg).  Full Article

China Resources Double-Crane Pharmaceutical gets nod for clinic trial
Tuesday, 16 Feb 2016 07:00pm EST 

China Resources Double-Crane Pharmaceutical Co Ltd:Says gets China Food and Drug Administration's approval for its ultrasonic contrast agent injection's clinic trial.  Full Article

China Resources Double-Crane Pharmaceutical subsidiary receives drug clinical trial permission
Thursday, 4 Feb 2016 07:00pm EST 

China Resources Double-Crane Pharmaceutical Co Ltd:Says its subsidiary receives drug clinical trial permission for strontium ranelate for suspension.  Full Article

More From Around the Web